Omega-3 Supplements for Dry Eyes: Evidence Review
How Omega-3 Supplements Help Dry Eye
Omega-3 fatty acids have long been discussed as a natural approach to managing dry eye disease, but the clinical evidence behind their use is more nuanced than many patients realize. Whether you have been told to take fish oil for dry eyes or are researching the topic on your own, understanding what the science actually shows can help you make a more informed decision about your care. Omega-3 fatty acids are thought to benefit dry eye through their anti-inflammatory properties, which may improve the health of the tear film and the oil-producing glands along the eyelid margin.
Chronic inflammation of the ocular surface is a central driver of dry eye disease. When the oil-producing glands in the eyelids (meibomian glands) become inflamed or blocked, they produce less of the oily layer that prevents tears from evaporating too quickly. Omega-3 fatty acids, specifically eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), are metabolized into anti-inflammatory compounds called resolvins and protectins that may help calm this cycle of surface inflammation.
Some studies have shown that omega-3 supplementation can improve tear breakup time, which measures how quickly the tear film becomes unstable after a blink. Improved tear stability means the eye surface stays better protected between blinks, reducing the burning, stinging, and fluctuating vision that many dry eye patients experience. Omega-3s may also reduce tear osmolarity, a marker of how concentrated and irritating the tears have become.
Because omega-3 fatty acids can modify the composition of the oils secreted by the meibomian glands, they may help improve the quality of the tear film's outer oily layer. Healthier meibomian gland secretions flow more easily and spread more evenly across the eye surface, reducing common dry eye symptoms such as grittiness, redness, and discomfort. This mechanism is particularly relevant for patients whose dry eye is driven by meibomian gland dysfunction, the most common subtype of the condition.
What the Research Says About Omega-3 and Dry Eye
The clinical evidence on omega-3 and dry eye includes large randomized controlled trials, meta-analyses, and a Cochrane systematic review, with results that are not always in agreement. The Dry Eye Assessment and Management (DREAM) study, published in 2018, was the largest randomized controlled trial on this topic. Funded by the National Eye Institute, it enrolled 535 patients with moderate-to-severe dry eye and assigned them to receive either 3,000 mg of omega-3 fatty acids daily or an olive oil placebo for 12 months. According to the DREAM Study, omega-3 supplementation did not show a statistically significant benefit over placebo for moderate-to-severe dry eye in this large randomized trial (DREAM Study, New England Journal of Medicine, 2018).
Several aspects of the DREAM study have been debated in the ophthalmology community. The study used ethyl ester omega-3 supplements, which are less bioavailable than the re-esterified triglyceride (rTG) form used in other positive trials. Additionally, the olive oil placebo itself contains oleic acid, which has its own anti-inflammatory properties, potentially masking any benefit from omega-3. Some experts argue these design choices may have underestimated the true effect of omega-3 supplementation.
Several smaller trials and meta-analyses have reached different conclusions. A 2014 meta-analysis of randomized controlled trials found that omega-3 supplementation significantly improved tear breakup time and Schirmer test scores, both objective measures of tear film health. A large 2023 randomized trial in symptomatic screen users found significant improvements in dry eye symptoms and tear film parameters with omega-3 supplementation compared to olive oil placebo, with greater benefit in patients who had low baseline omega-3 levels.
A Cochrane systematic review found that long-chain omega-3 supplements alone may have little to no benefit relative to placebo on dry eye symptoms but did improve some clinical signs. However, when omega-3 supplements were combined with standard dry eye treatments such as artificial tears, warm compresses, or prescription eye drops, there was a clear beneficial effect on symptoms compared to standard treatment alone. This suggests omega-3 may be most helpful as part of a comprehensive treatment approach rather than a standalone therapy.
What Type of Omega-3 Is Best for Dry Eye
Not all omega-3 supplements are the same, and the form and source can influence how well they are absorbed and how effectively they reach the tissues that matter. Fish oil contains the long-chain omega-3 fatty acids EPA and DHA, which are the forms most directly involved in reducing inflammation. Flaxseed oil provides alpha-linolenic acid (ALA), a plant-based omega-3 that the body must convert into EPA and DHA before it can be used. This conversion process is inefficient, with only about 5 to 15 percent of ALA ultimately reaching the EPA stage and even less becoming DHA. For this reason, fish oil or algae-based omega-3 supplements are generally considered more effective for dry eye support.
Both EPA and DHA contribute to the anti-inflammatory effects relevant to dry eye, but most clinical studies that showed positive results used formulations with a higher proportion of EPA relative to DHA. EPA is the primary precursor to the anti-inflammatory resolvins that help calm ocular surface inflammation. A ratio of approximately two parts EPA to one part DHA is commonly used in clinical research on dry eye.
Omega-3 supplements come in several chemical forms, including ethyl esters, standard triglycerides, and re-esterified triglycerides (rTG). The rTG form has been shown to have significantly higher bioavailability, meaning more of the active EPA and DHA reaches the bloodstream after ingestion. Multiple clinical studies using the rTG form have demonstrated improvements in tear osmolarity, tear breakup time, and inflammatory markers such as matrix metalloproteinase-9 (MMP-9) in dry eye patients. When selecting a supplement, looking for the rTG form on the label may help ensure better absorption.
For patients who do not eat fish or prefer a plant-based option, algae-derived omega-3 supplements provide EPA and DHA directly without the need for conversion from ALA. Algae-based supplements also avoid the concerns about mercury and other contaminants sometimes associated with fish oil products. While fewer dry eye studies have specifically tested algae-based omega-3, the active compounds are chemically identical to those found in fish oil.
Recommended Dosage and Dietary Sources
Dosage recommendations vary depending on the study and the supplement formulation, but a general range has emerged from the clinical literature. Most dry eye studies that showed positive results used total daily omega-3 doses in the range of 2,000 to 3,000 mg, with a significant proportion coming from EPA. The DREAM study used 3,000 mg per day consisting of 2,000 mg EPA and 1,000 mg DHA. Smaller positive studies have used dosages as low as 1,000 to 1,500 mg of combined EPA and DHA daily. Our dry eye specialists can help determine the right dosage based on your individual symptoms and overall health.
The total fish oil content listed on a supplement label is not the same as the omega-3 content. A capsule labeled as 1,000 mg of fish oil may contain only 300 to 500 mg of actual EPA and DHA combined. To reach a therapeutic dose for dry eye, you need to look at the EPA and DHA amounts specifically, not the total oil content. This distinction is a common source of confusion and may explain why some patients do not experience benefit from their supplement.
In addition to supplements, omega-3 fatty acids can be obtained from dietary sources such as salmon, mackerel, sardines, anchovies, and herring. Two to three servings per week of fatty fish can provide a meaningful amount of EPA and DHA. Walnuts, chia seeds, and ground flaxseeds provide ALA, which is less efficiently converted but still contributes to overall omega-3 intake. Pairing dietary omega-3 with other home care strategies such as lid hygiene and warm compresses can create a more effective daily routine for managing dry eye.
Frequently Asked Questions
Most clinical studies that demonstrated improvement observed changes beginning around six weeks, with more consistent results by 12 weeks of daily use. Some patients notice subtle changes sooner, while others may need three months or longer before a meaningful difference becomes apparent. Consistent daily use is important because the anti-inflammatory effects build gradually as omega-3 levels increase in your tissues.
Several studies suggest that the re-esterified triglyceride (rTG) form of omega-3 may produce better outcomes for dry eye patients than the ethyl ester form. The rTG form is more readily absorbed by the body, meaning more EPA and DHA reach your bloodstream with each dose. One study found that 12 weeks of rTG omega-3 supplementation significantly improved tear osmolarity, tear breakup time, and surface inflammation markers in patients with dry eye and meibomian gland dysfunction.
The DREAM study found that patients taking 3,000 mg of omega-3 daily for 12 months did not improve significantly more than patients taking an olive oil placebo, as both groups experienced meaningful symptom relief. However, the study has been discussed extensively because it used the less bioavailable ethyl ester form and because olive oil itself may have anti-inflammatory properties that could have influenced the placebo group's results.
Omega-3 supplements should not be considered a replacement for other proven dry eye treatments. The strongest evidence supports omega-3 as a complementary therapy used alongside treatments such as artificial tears, prescription anti-inflammatory drops, warm compresses, and in-office procedures like LipiFlow. Patients with moderate-to-severe dry eye typically need a layered treatment approach, and omega-3 may help optimize results when combined with other therapies.
The most common side effects are mild gastrointestinal symptoms, including fishy aftertaste, burping, nausea, or loose stools. Taking supplements with meals can reduce these effects. At very high doses, omega-3 supplements may have a mild blood-thinning effect, so patients taking anticoagulant medications should discuss supplementation with their physician before starting. Choosing a high-quality, purified product can also help minimize unwanted taste and digestive discomfort.
Yes, omega-3 supplements can generally be used alongside prescription dry eye drops such as cyclosporine or lifitegrast. Because omega-3 works through a different mechanism than these medications, the two approaches can complement each other. A comprehensive dry eye evaluation can help our specialists determine how omega-3 fits into your personalized treatment plan alongside any prescription therapies you are currently using.
What our Patients say
4.8
Reviews
(3547)